NCT00005627View on ClinicalTrials.gov

Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 1999

Study Completion Date

April 30, 2003

Conditions

Prostate Cancer

Interventions

DRUG

carboplatin

DRUG

docetaxel

DRUG

estramustine phosphate sodium

Trial Locations (2)

02114

Massachusetts General Hospital Cancer Center, Boston

02115

Dana-Farber Cancer Institute, Boston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER

NCT00005627 - Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter